The forecast for private non-profit expenditure on R&D in medical and health sciences in Italy indicates a declining trend from 2024 to 2028, with values decreasing from $389.36 million to $383.6 million PPP. The year-on-year decline from 2024 onward is relatively consistent, reflecting subdued investment interest or constraints in the sector. In 2023, expenditures were slightly higher than 2024 projections, suggesting recent downward pressure. The compound annual growth rate over five years highlights a minor negative trend, emphasizing the gradual decrease in spending.
Future trends to watch include potential shifts in policy incentives, increased focus on digital healthcare innovations, or collaborations that could reverse this decline. Monitoring Italy's economic context and health priorities will be crucial for anticipating shifts in R&D investments.
